In this issue:
Quality of IBD care in Australia
Risk of lymphoma with thiopurines or biologics in Japanese patients
Endoscopic techniques for dysplasia surveillance in IBD
Thiopurine use and keratinocyte carcinoma
Antibiotics and probiotics in IBD
Opioids: gut dysbiosis and exacerbation of colitis
Safety of a schistosome helminth-derived protein in CD
Patients’ perceptions of biologics
Risk factors for medication non-adherence to self-injectable biologics
Oral nutrition supplements and TGF-β2 in CD
Science blog: JAK Inhibitors – the immune response and the immune therapies
Please login below to download this issue (PDF)